Ty21a-ETEC

N/A

Report date: 2025/01/26 17:34:54

Base Information

Drug NameTy21a-ETEC
Drug Alias NameETEC Ty21a-vectored recombinant live-attenuated multivalent vaccine (Protein Potential/Sanaria)
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Development/production technology > Recombinant vector vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsTyphoid FeverEscherichia coli InfectionsDysentery, Bacillary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesProtein Potential LLC
China Registration ClassN/A

Develop Information

Active CompaniesProtein Potential LLCSanaria Inc
Inactive CompaniesN/A
Active IndicationsTyphoid FeverEscherichia coli InfectionsDysentery, Bacillary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A